Rocuronium
NDC 65219-065, ROCURONIUM BROMIDE, injection, solution, from Fresenius Kabi USA, LLC.
- Product NDC
- 65219-065
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078651
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65219-065 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ROCURONIUM BROMIDE10 mg/mL
Pharmacologic classes
Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65219-065-05 | 65219006505 | 10 VIAL in 1 TRAY (65219-065-05) / 5 mL in 1 VIAL (65219-065-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/209a654d-f92d-4242-bfef-2dcc90a30d3f
Use it
Look up 65219-065 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65219-065 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65219-065. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.